Edible oil major, Marico Industries, had recently declared its second quarter FY02 results. It posted a marginal 1.8% growth in sales YoY but its bottomline growth was more or less stagnant YoY. On a consolidated half yearly basis, Marico declared 1.6% growth in topline and a marginal 3.5% growth in net profit.
Operating Profit (EBDIT)
Operating Profit Margin (%)
Profit before Tax
Profit after Tax/(Loss)
Net profit margin (%)
No. of Shares
Diluted Earnings per share*
At first glance the turnover growth looks discouraging. However, according to the company, the volume growth was significant, but due to lower product prices, the value figures were depressed. Infact, in 1HFY02, the coconut oil segment (Parachute and Oil of Malabar) grew by 9%.
But in the refined oil category Marico witnessed a de-growth in Sunflower oil segment. Post Union Budget 2001, the custom duty rate on imported sunflower oil increased substantially (to 75%) while duty hike for other oils like soya (45%) was not so steep. This resulted in the relative price of sunflower oil being higher than other oils, resulting in a shift in the consumer preference towards cheaper oils. Marico however, focused on maintaining the margins on its sunflower oil brand. Consequently, there has been a marginal de-growth in Sweekar sales volumes during 1HFY02 as compared to 1HFY01, leading to a fall in Marico's overall refined oil market share.
Market Share %
Parachute & Oil of Malabar (OOM)
Saffola & Sweekar
Refined Oils in Consumer Packs (ROCP)
Hair & Care
Non-Sticky Hair Oils (NSHO)
Parachute Jasmine, Parachute Lite and Parachute Dandruff Solution
Value Added Coconut Oils
Shanti Amla (for April 01 to Aug 01)
Amla Hair Oils
ORG-Urban Retail data for the 12-month period ended August 2001
The realisations of Parachute coconut oil were lower in 1HFY02. For example, the maximum retail price (MRP) of the largest selling pack (200 ml bottle) in 1HFY02 was lower at Rs 22.75, as compared to Rs 26 per bottle during 1HFY01. Added to that, sales of P&G (Proctor and Gamble) products fell, primarily because P&G withdrew the brands Clearasil/Ultra Clearasil (divested) and Camay Soap (discontinued) from the distribution agreement.
Raw material consumed
Packing material consumed
Advertising and sales promotion
At the current market price of Rs 220 the stock trades at a P/e multiple of 6x annualised 1HFY02 earnings and a market cap to sales ratio of 0.5x. The valuations are on the lower side of the FMCG spectrum. Given the company's focus on the edible oil business and its ability to maintain its market share and growth despite HLL's entry into the segment, the company should have been rated higher. Also, the company has a consistent dividend paying track record.
But concerns are that in these difficult market conditions, Marico, may continue to face pressure of pricing power. Though in this quarter, its expenditure has been under control due to lower advertising costs, competitive pressures and a difficult market may see an escalation in these costs in the coming quarters.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407